Delivery Order SPE2DB22D3301-SPE2DB25FY9PR
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Gel-One 30 mg/3 mL syringes with a ceiling value of $1,094.70. This is a firm fixed-price delivery order with an ultimate completion date of September 8, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,824.50 to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 mL syringes on July 30, 2025, with an ultimate completion date of August 20, 2025. This competitive contract award, which carries no set-aside designation, is structured as a firm fixed price delivery order. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,649.00 to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 mL syringes. This firm fixed-price delivery order, issued on August 4, 2025, with an ultimate completion date of August 25, 2025, represents a competitive award with no set-aside designation. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. As a child order...
- The Defense Logistics Agency awarded a $4,378.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 mL syringes on July 30, 2025, with an ultimate completion date of August 20, 2025. This is a non-set-aside contract executed under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle valued through December 2026. The place of performance is AmerisourceBergen's corporate...
- The U.S. Defense Logistics Agency (DLA) awarded a $7,054.40 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of 4565562938 - GEL-ONE 30 MG/3 ML SYRINGE 3ML, with a completion date of August 22, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that supplies essential medical commodities, including prescription drugs, vaccines, and medical supplies, to various federal agencies and healthcare...
- The Defense Logistics Agency awarded a $3,649.00 delivery order contract to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 mL syringes (3 mL quantity) with an ultimate completion date of September 9, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for GEL-ONE 30 MG/3 ML SYRINGE 3ML. The potential value of this contract is $1,763.60 and the completion date is March 12, 2024. Amerisourcebergen Drug Corp provides a wide range of pharmaceutical products and medical supplies to U.S. government agencies, including the Department of Defense, through indefinite delivery...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $10,228.88 contract is for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a pharmaceutical product, with a completion date of May 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025 for a...
- This is a $4,013.90 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 30 mg/3 mL GEL-ONE syringes. The contract has an ultimate completion date of July 25, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp also holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which provides a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,473.50, is for the delivery of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a medical product. The contract is a firm fixed-price, non-set-aside arrangement with a performance period through May 21, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY9PRDelivery Order
The Defense Logistics Agency awarded a $14,596 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Gel-One 30 mg/3 mL syringes. The contract, which is competitively awarded with no set-aside designation, carries a firm fixed price structure and an ultimate completion date of September 10, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a leading pharmaceutical distributor and healthcare solutions provider. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. As a critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical devices to support military healthcare programs globally, including support to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's demonstrated capacity to manage both small and substantial orders through open competition positions it as a key supplier within the DLA's Pharmaceutical Prime Vendor Global Program framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.6k | 8/19/25 |